Copyright
©The Author(s) 2015.
World J Gastroenterol. Mar 28, 2015; 21(12): 3571-3578
Published online Mar 28, 2015. doi: 10.3748/wjg.v21.i12.3571
Published online Mar 28, 2015. doi: 10.3748/wjg.v21.i12.3571
Table 1 Genotypes and methods of analysis considered in this study
Gene | Polymorphism | Method | References |
NAT1 | T1088A | Sequencing | With primer forward: 5’-TGCCCAAACATGGTGATAGATTT-3’ |
With primer reverse: 5’-CCATAAAACTTTTCTAGGAATTCAACAAT-3’ | |||
NAT1 | C1095A | Sequencing | As above |
NAT2 | C282T | PCR-RFLP | [23,24] |
NAT2 | T341C | PCR-RFLP | [23,24] |
TPMT | G238C | PCR-ASO | [27] |
TPMT | G460A | PCR-RFLP | [27] |
TPMT | A719G | PCR-RFLP | [27] |
ITPA | C94A | TaqMan | TaqMan SNP genotyping assay from |
Applied biosystems (C_27465000_10) |
- Citation: Stocco G, Cuzzoni E, Iudicibus SD, Favretto D, Malusà N, Martelossi S, Pozzi E, Lionetti P, Ventura A, Decorti G. Thiopurine metabolites variations during co-treatment with aminosalicylates for inflammatory bowel disease: Effect of N-acetyl transferase polymorphisms. World J Gastroenterol 2015; 21(12): 3571-3578
- URL: https://www.wjgnet.com/1007-9327/full/v21/i12/3571.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i12.3571